The More Life Company Advancing U.S. Compounded Pharmaceutical Commercialization Pathway for Quicksome™

Strategic LOI advances U.S. compounding capability for a growing portfolio of potential Quicksome-enabled pharmaceutical applications TORONTO — The More Life Company Corp. (the “Company” or “MLCO”), (CSE: MLCO) (OTC: TMLCF) is pleased to announce that it has entered into a strategic letter of intent (“LOI”) with an established U.S. 503A compounding pharmacy to advance the […]